Viewing Study NCT01285518


Ignite Creation Date: 2025-12-25 @ 4:50 AM
Ignite Modification Date: 2025-12-26 @ 3:51 AM
Study NCT ID: NCT01285518
Status: COMPLETED
Last Update Posted: 2016-11-18
First Post: 2011-01-26
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Safety And Tolerability Of Escalating Intravenous Doses Of PF-05231023 In Adult Subjects With Type 2 Diabetes
Sponsor: Pfizer
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2011-02
Start Date Type: None
Primary Completion Date: 2011-07
Primary Completion Date Type: ACTUAL
Completion Date: 2011-07
Completion Date Type: ACTUAL
First Submit Date: 2011-01-26
First Submit QC Date: None
Study First Post Date: 2011-01-28
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2014-12-18
Results First Submit QC Date: None
Results First Post Date: 2016-11-18
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2016-09-27
Last Update Post Date: 2016-11-18
Last Update Post Date Type: ESTIMATED